Year archive

Appili Therapeutics Inc. — 2024 filings

All 46 regulatory filings released by Appili Therapeutics Inc. (APLI) in 2024, sourced directly from the official regulator.

46 Filings

2024 Period

2024 filings (46)

Filing	Released	Lang
News release - English.pdf M&A Activity	2024-11-19	English
52-109F2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2024-11-14	English
52-109F2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2024-11-14	English
Interim financial statements/report – English.pdf Interim / Quarterly Report	2024-11-14	English
Interim MD&A - English.pdf Interim / Quarterly Report	2024-11-14	English
News release - English.pdf Interim / Quarterly Report	2024-11-14	English
News release - English.pdf Regulatory Filings	2024-10-31	English
Notice of meeting - English.pdf Proxy Solicitation & Information Statement	2024-10-10	English
Form of proxy - English.pdf Proxy Solicitation & Information Statement	2024-10-10	English
Other.pdf Annual Report	2024-10-10	English
News release - English.pdf M&A Activity	2024-10-10	English
News release - English.pdf Proxy Solicitation & Information Statement	2024-10-10	English
Other material contracts (amended) - English.pdf M&A Activity	2024-09-03	English
Notice of meeting - English.pdf Regulatory Filings	2024-08-21	English
Other.pdf Regulatory Filings	2024-08-21	English
Form of proxy - English.pdf Proxy Solicitation & Information Statement	2024-08-21	English
Management information circular - English.pdf Proxy Solicitation & Information Statement	2024-08-21	English
News release - English.pdf M&A Activity	2024-08-21	English
Notice of the meeting and record date (amended) - French.pdf Regulatory Filings	2024-08-16	English
Interim financial statements/report – English.pdf Interim / Quarterly Report	2024-08-14	English
Interim MD&A - English.pdf Interim / Quarterly Report	2024-08-14	English
52-109F2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2024-08-14	English
52-109F2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2024-08-14	English
News release - English.pdf Interim / Quarterly Report	2024-08-13	English
Notice of the meeting and record date - English.pdf Regulatory Filings	2024-07-24	English
Notice of the meeting and record date - French.pdf Declaration of Voting Results & Voting Rights Announcements	2024-07-24	English
Other material contracts (amended) - English.pdf M&A Activity	2024-07-23	English
News release - English.pdf Capital/Financing Update	2024-07-02	English
52-109F1 - Certification of annual filings - CEO (E).pdf Regulatory Filings	2024-06-26	English
52-109F1 - Certification of annual filings - CFO (E).pdf Regulatory Filings	2024-06-26	English
Annual information form - English.pdf Annual Report	2024-06-26	English
Annual MD&A - English.pdf Management Reports	2024-06-26	English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2024-06-26	English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2024-06-26	English
Audited annual financial statements – English.pdf Annual Report	2024-06-26	English
News release - English.pdf Annual Report	2024-06-25	English
News release - English.pdf Capital/Financing Update	2024-04-27	English
Material document(s).pdf M&A Activity	2024-04-08	English
Material document(s).pdf Merger & Acquisition	2024-04-08	English
Material change report - English.pdf M&A Activity	2024-04-08	English
News release - English.pdf Declaration of Voting Results & Voting Rights Announcements	2024-04-02	English
News release - English.pdf Interim / Quarterly Report	2024-02-14	English
52-109F2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2024-02-14	English
52-109F2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2024-02-14	English
Interim MD&A - English.pdf Interim / Quarterly Report	2024-02-14	English
Interim financial statements/report – English.pdf Interim / Quarterly Report	2024-02-14	English